🇺🇸 Sodium Aescinate in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 12

Most-reported reactions

1. Dyspnoea — 2 reports (16.67%)
2. Rash — 2 reports (16.67%)
3. Abdominal Distension — 1 report (8.33%)
4. Atrial Fibrillation — 1 report (8.33%)
5. Cerebrovascular Insufficiency — 1 report (8.33%)
6. Condition Aggravated — 1 report (8.33%)
7. Dermatitis Allergic — 1 report (8.33%)
8. Dizziness — 1 report (8.33%)
9. Dry Throat — 1 report (8.33%)
10. Erythema — 1 report (8.33%)

Source database →

Frequently asked questions

Is Sodium Aescinate approved in United States?

Sodium Aescinate does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Sodium Aescinate in United States?

Beijing Tiantan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.